Plain-English translation of NCT07225530 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach to cervical cancer screening for women living with HIV. Instead of the usual process where screening, test results, and treatment happen over multiple visits, the iSTAR approach does all three steps in a single visit — you get screened, find out your results the same day, and receive treatment if needed right away.
Women living with HIV are at much higher risk for cervical cancer, and the Dominican Republic has particularly high rates of this disease. Many women don't complete the standard multi-visit screening and treatment process, which means precancerous changes go untreated. This trial aims to see if getting everything done in one day helps more women get the care they need.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either the standard approach or the new same-day screening approach. If assigned to the new approach, you will have a single visit where you receive an HPV screening test, get your results the same day, and if you have precancerous changes suitable for treatment, you can receive ablative therapy (a procedure that removes abnormal tissue) during that same visit. If your condition requires more advanced care, you will be referred to a specialist. The trial will follow 600 women total.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Dominican Republic